TY - JOUR
T1 - Indium-labeled macrocyclic conjugates of naltrindole
T2 - High-affinity radioligands for in vivo studies of peripheral δ opioid receptors
AU - Duval, Romain A.
AU - Allmon, Rachel L.
AU - Lever, John R.
PY - 2007/5/3
Y1 - 2007/5/3
N2 - We have identified a series of hydrophilic indium-labeled DOTA and DO3A conjugates of naltrindole (NTI) that are suited to in vivo studies of peripheral δ opioid receptors. Indium(III) complexes, linked to the indole nitrogen of NTI by six- to nine-atom spacers, display high affinities (0,1-0,2 nM) and excellent selectivities for binding to δ sites in vitro. The [ 111In]-labeled complexes can be prepared in good isolated yields (∼65%) with high specific radioactivities (>3300 mCi/μmol), The spacers serve as pharmacokinetic modifiers, and log D7.4 values range from -2,74 to -1,79, These radioligands exhibit a high level of specific binding (75-94%) to δ opioid receptors in mouse gut, heart, spleen, and pancreas in vivo. Uptakes of radioactivity are saturable by the non-radioactive complexes, inhibited by naltrexone, and blocked by NTI. Thus, these radiometal-labeled NTI analogues warrant further study by single-photon emission computed tomography.
AB - We have identified a series of hydrophilic indium-labeled DOTA and DO3A conjugates of naltrindole (NTI) that are suited to in vivo studies of peripheral δ opioid receptors. Indium(III) complexes, linked to the indole nitrogen of NTI by six- to nine-atom spacers, display high affinities (0,1-0,2 nM) and excellent selectivities for binding to δ sites in vitro. The [ 111In]-labeled complexes can be prepared in good isolated yields (∼65%) with high specific radioactivities (>3300 mCi/μmol), The spacers serve as pharmacokinetic modifiers, and log D7.4 values range from -2,74 to -1,79, These radioligands exhibit a high level of specific binding (75-94%) to δ opioid receptors in mouse gut, heart, spleen, and pancreas in vivo. Uptakes of radioactivity are saturable by the non-radioactive complexes, inhibited by naltrexone, and blocked by NTI. Thus, these radiometal-labeled NTI analogues warrant further study by single-photon emission computed tomography.
UR - http://www.scopus.com/inward/record.url?scp=34247646912&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34247646912&partnerID=8YFLogxK
U2 - 10.1021/jm0700013
DO - 10.1021/jm0700013
M3 - Article
C2 - 17402725
AN - SCOPUS:34247646912
SN - 0022-2623
VL - 50
SP - 2144
EP - 2156
JO - Journal of medicinal chemistry
JF - Journal of medicinal chemistry
IS - 9
ER -